Cardio-oncology A-Z
Published: 13 June 2022
-
Views:
1026 -
Likes:
7
-
Views:
1026 -
Likes:
7
-
Up Next
-
9m 6sPart 1 | Session 3 The Role of Big Data in Driving Cardio-oncology Forward With Dr Avirup Guha
-
8m 22sPart 1 | Session 4 Late Effects Cardiotoxicity With Dr Neha Bansal
-
5m 38sPart 1 | Session 5 CMR in Cardio-oncology With Dr Lauren Baldassarre
-
3m 55sPart 1 | Session 6 Arrhythmias in Cancer Patients with Dr Michael Fradley
-
5m 54sPart 1 | Session 7 CAR-T Cell Cardiotoxicity with Dr Daniel Chen
-
10mPart 1 | Session 1 Breast Cancer Treatment Related Cardiotoxicity With Dr Anne Blaes
Overview
In recent years, cardio-oncology (CO) emerged as a subspeciality focusing on the cardiac management of cancer patients. In our new Cardio-oncology A to Z series we are aiming to provide you short summaries of CO concepts curated by Dr Arjun Ghosh and delivered by practising experts of this field.
The first instalment of this series includes talks on:
- Breast Cancer Treatment Related Cardiotoxicity With Dr Anne Blaes
- Radiation Induced Heart Disease With Dr Joshua Mitchell
- The Role of Big Data in Driving Cardio-oncology Forward With Dr Avirup Guha
- Late Effects Cardiotoxicity With Dr Neha Bansal
- CAR T cell cardiotoxicity With Dr Dan Chen
- CMR in cardio-oncology With Dr Lauren Baldassare
- Arrhythmias in cancer patients With Dr Mike Fradley
More from this programme
Part 1
Faculty Biographies
Joshua Mitchell
Assistant Professor of Medicine at Washington University School of Medicine and the Director of our Cardio-Oncology Centre Of Excellence
Prof Joshua Mitchell is Director of Cardio-Oncology Center of Excellence at Washington University School of Medicine in St Louis, US. Prof Mitchell is a distinguished expert in cardio-oncology and cardiac amyloidosis. His research focuses on optimising prevention, screening, and management of cardiac complications from cancer therapies and enhancing the diagnosis and care of cardiac amyloid patients.